Twice-weekly ixazomib in combination with lenalidomide-dexamethasone in patients with newly diagnosed multiple myeloma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Twice-weekly ixazomib in combination with lenalidomide-dexamethasone in patients with newly diagnosed multiple myeloma

Published:2018-06-25 Issue:2 Volume:182 Page:231-244
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

Richardson Paul G.¹^ORCID,Hofmeister Craig C.²,Rosenbaum Cara A.³,Htut Myo⁴,Vesole David H.⁵,Berdeja Jesus G.⁶,Liedtke Michaela⁷^ORCID,Chari Ajai⁸,Smith Stephen D.⁹,Lebovic Daniel¹⁰,Raje Noopur¹¹,Byrne Catriona¹²,Liao Eileen¹²,Gupta Neeraj¹²^ORCID,Bacco Alessandra Di¹²,Estevam Jose¹²,Berg Deborah¹²,Baz Rachid¹³

Affiliation:

1. Dana-Farber Cancer Institute; Boston MA USA

2. Ohio State University; Columbus OH USA

3. Hematology/Oncology; University of Chicago Medicine; Chicago IL USA

4. Hematology and Stem Cell Transplant; City of Hope National Medical Center Duarte; Duarte CA USA

5. John Theurer Cancer Center; Hackensack University Medical Center; Hackensack NJ USA

6. Sarah Cannon Research Institute; Nashville TN USA

7. Stanford Comprehensive Cancer Center; Stanford CA USA

8. Mount Sinai School of Medicine Ruttenberg Treatment Center; New York NY USA

9. Fred Hutchinson Cancer Research Center; University of Washington; Seattle WA USA

10. University of Michigan Cancer Center; Ann Arbor MI USA

11. Massachusetts General Hospital; Boston MA USA

12. Millennium Pharmaceuticals Inc.; Cambridge MA USA

13. Malignant Hematology, H. Lee Moffitt Cancer Center & Research Institute; Tampa FL USA

Funder

Millennium Pharmaceuticals, Inc.

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bjh.15394/fullpdf

Reference46 articles.

1. Lenalidomide maintenance after stem-cell transplantation for multiple myeloma;Attal;New England Journal of Medicine,2012

2. Curing myeloma at last: defining criteria and providing the evidence;Barlogie;Blood,2014

3. Good publication practice for communicating company-sponsored medical research: GPP3;Battisti;Annals of Internal Medicine,2015

4. Development of a conceptual model to illustrate the impact of multiple myeloma and its treatment on health-related quality of life;Baz;Supportive Care in Cancer,2015

5. Lenalidomide and dexamethasone in transplant-ineligible patients with myeloma;Benboubker;New England Journal of Medicine,2014

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ixazomib, Lenalidomide, and Dexamethasone (IRD) Treatment with Cytogenetic Risk-Based Maintenance in Transplant-Eligible Myeloma: A Phase 2 Multicenter Study by the Nordic Myeloma Study Group;Cancers;2024-02-29

2. Mir-186 inhibits the proliferation and growth of multiple myeloma cells by targeting Jagged-1 expression;Tropical Journal of Pharmaceutical Research;2024-02-05

3. Efficacy and safety of daratumumab with ixazomib and dexamethasone in lenalidomide‐exposed patients after one prior line of therapy: Final results of the phase 2 study DARIA;American Journal of Hematology;2024-01-31

4. Proteasome inhibition in combination with immunotherapies: State-of-the-Art in multiple myeloma;Blood Reviews;2023-09

5. Ensuring Diversity and Inclusion in Clinical Development by Leveraging Community Oncology Centers;Journal of the National Comprehensive Cancer Network;2023-08

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3